ARTICLE | Financial News
Dermatology play Thesan closes $49 million B round
February 25, 2014 1:03 AM UTC
Thesan Pharmaceuticals Inc. (Carlsbad, Calif.) closed a $49 million series B round led by existing investor Novo Ventures. New investors SV Life Sciences and Lundbeckfond Ventures also participated, along with existing investor Novartis Venture Fund. SV's Michael Ross and Lundbeckfond's Mette Kirstine Agger joined Thesan's board. ...